Testing a new easy-change heart valve replacement system
Part of Heart & circulation clinical trials.
This study tests a biological (tissue) heart valve replacement system designed to be easier to change later. It may help people who need valve surgery because their valve is narrowed or damaged.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need surgery for a diseased aortic valve, with specific heart scan results
- Your aortic valve narrowing may be severe, or moderate if you also need bypass surgery
- You also have mitral valve disease that requires surgery
- You should not need replacement of two or more heart valves
- Your heart pumping strength (LVEF) must be 45% or higher
- You must be able and willing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a new replacement heart valve works and how safe it is. You might qualify if you need a planned first-time aortic valve replacement and are 60-70 years old (or younger if you cannot take blood thinners).
This study tests a new biological heart valve called 'UniLine' for people who need to replace their mitral valve (the valve between the left heart chambers) or aortic valve (the main valve sending blood to the body) for the first time. If you qualify, you would have planned surgery (not an emergency) and need to be free of certain other serious health conditions.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
This study tests a new type of prosthetic heart valve made from a special polymer material. It is for adults who need surgical replacement of either the mitral or aortic valve.
This study compares a new artificial aortic valve (Myval THV) with standard medical treatment for people with moderate aortic stenosis—a condition where the heart valve doesn't open fully. The trial tests whether the new valve can help improve symptoms and heart function.
Hear when a new Heart Valve Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.